Skip to content

Clinical trials

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20204
20211
20221
20243
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Active, not recruiting3
Completed2
Not yet recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tongji Hospital5
Sanofi3
argenx3
Bioverativ, a Sanofi company1
Dianthus Therapeutics1
First Affiliated Hospital of Fujian Medical University1
Janssen Research & Development, LLC1
Sichuan Academy of Medical Sciences1
Tianjin Huanhu Hospital1
Tianjin Medical University General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating19
Myasthenia Gravis8
Autoimmune Diseases of the Nervous System7
Multiple Sclerosis7
Neuromyelitis Optica7
Myositis5
Autoimmune Diseases2
Guillain-Barre Syndrome2
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease2
Encephalomyelitis, Acute Disseminated1

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.